Two distinct effector memory cell populations of WT1 (Wilms’ tumor gene 1)-specific cytotoxic T lymphocytes in acute myeloid leukemia patients Yoshiki NakaeYoshihiro OkaHaruo Sugiyama Original Article 03 April 2015 Pages: 791 - 804
Adoptive T cell therapy combined with intralesional administrations of TG1042 (adenovirus expressing interferon-γ) in metastatic melanoma patients Amir KhammariJean-Michel NguyenBrigitte Dreno Original Article 07 April 2015 Pages: 805 - 815
Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T Rachel A. BurgaMitchell ThornSteven C. Katz Original Article 08 April 2015 Pages: 817 - 829
Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions Yannick WillemenJohan M. J. Van den BerghEvelien L. J. Smits Original Article 12 April 2015 Pages: 831 - 842
Persistent HPV16/18 infection in Indian women with the A-allele (rs6457617) of HLA-DQB1 and T-allele (rs16944) of IL-1β −511 is associated with development of cervical carcinoma Sankhadeep DuttaChandraditya ChakrabortyChinmay Kumar Panda Original Article 17 April 2015 Pages: 843 - 851
Cytotoxic T lymphocyte antigen 4 expression in human breast cancer: implications for prognosis Haiming YuJunlan YangJiandong Wang Original Article Open access 17 April 2015 Pages: 853 - 860
Development of a potent melanoma vaccine capable of stimulating CD8+ T-cells independently of dendritic cells in a mouse model Katie L. PowellAlexandre S. StephensStephen J. Ralph Original Article 19 April 2015 Pages: 861 - 872
Immunostimulatory early phenotype of tumor-associated macrophages does not predict tumor growth outcome in an HLA-DR mouse model of prostate cancer Vladimir RiabovDavid KimElena N. Klyushnenkova Original Article 19 April 2015 Pages: 873 - 883
Immune checkpoint combinations from mouse to man Midan AiMichael A. Curran Focussed Research Review 03 January 2015 Pages: 885 - 892
Orchestrating an immune response against cancer with engineered immune cells expressing αβTCRs, CARs, and innate immune receptors: an immunological and regulatory challenge Moniek A. de WitteGuido J. J. KierkelsJürgen Kuball Focussed Research Review Open access 20 May 2015 Pages: 893 - 902
Adoptive immunotherapy of cancer utilizing genetically engineered lymphocytes Hiroaki IkedaHiroshi Shiku Focussed Research Review 04 June 2015 Pages: 903 - 909
Intratumoral immunotherapy for melanoma Manisha SinghWillem W. Overwijk Focussed Research Review 07 June 2015 Pages: 911 - 921
Cancer immunotherapy achieves breakthrough status: 12th annual meeting of the association for cancer immunotherapy (CIMT), Mainz, Germany, May 6–8, 2014 Björn-Philipp KlokeAndrea MahrCedrik M. Britten Meeting Report 30 December 2014 Pages: 923 - 930